May 16, 2018 / 12:46 PM / 3 months ago

BRIEF-Iterum Therapeutics Says Expects Initial Public Offering Price To Be Between $14 And $16 Per Share

May 16 (Reuters) -

* ITERUM THERAPEUTICS PLC SEES IPO OF 5,333,333 ORDINARY SHARES - SEC FILING

* ITERUM THERAPEUTICS SAYS EXPECTS INITIAL PUBLIC OFFERING PRICE TO BE BETWEEN $14.00 AND $16.00 PER SHARE

* ITERUM THERAPEUTICS - INTENDS TO USE ABOUT $65 MILLION OF IPO PROCEEDS TO FUND PHASE 3 CLINICAL TRIALS OF ORAL SULOPENEM, SULOPENEM IN THREE INDICATIONS

* ITERUM THERAPEUTICS - INTENDS TO USE ABOUT $15 MILLION OF IPO PROCEEDS FOR MILESTONE PAYMENTS TO PFIZER INC Source text: [bit.ly/2rMAthB]

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below